I don't like this coming from the company though:HairStemTM is an exciting new hair regenerating foam with a background of success in Korea. Made from a blend of AmStem's special HCSM blend and conventional oriental naturopathic prescriptions from 17 herbs, HairStemTM has been used for the treatment of male pattern baldness, several forms of alopecia, and dandruff. AmStem plans to validate these claims in the U.S. with clinical trials and consumer studies, while test marketing the product in the summer of 2010.
HCSM, or Human Conditioned Stem Cell Media, is AmStem's special version of an accepted cosmetic ingredient that is derived from proteins secreted by stem cells obtained from umbilical cord blood. The cord blood is collected from consenting donors and is a non-controversial source of stem cells. HCSM works by providing the skin with dynamic proteins and nutritional supplements to make it healthy, balanced and revitalized in its ability to renew itself.
How HairStemTM Works
By diluting neurotransmitters, immuno-modulators, cytokines, and hormones discharged when stress is incurred, HairStemTM has been used successfully in Korea without any reported side-effects, and is shown to assit in maintaining a healthy, natural condition of the hair and scalp. It reaches the hair follicle and sebaceous gland through skin or blood, where other "stem cell" products cannot reach.
The HairStemTM foam contains Stem Cell protein solution (HCSM), as well as natural herbal ingredients such as Cnidium officinale, Angelica gigas, and Paeonia root extracts using non-chemical preservation.
From what I can tell..the companies involved with this use umbilical cord blood/stem cells: "CSM, or Human Conditioned Stem Cell Media, is the Company’s proprietary version of an accepted ingredient that is derived from proteins secreted by stem cells processed from the Company’s own facility, one of the largest umbilical cord blood banks in the world"...which of course doesn't apply to "Obama's announcement to lift Federal funding limitations.." Unless there was another that was separate from the embryonic stem cell funding limitations. The funding should have gone more for non-embryonic research anyway..it's where there's been more success.AmStem is a new biotechnology company based in Northern California, in the watershed of stem cell innovation fueled by President Obama’s recent announcement to lift Federal funding limitations for stem cell research. AmStem provides biotherapeutic and cosmetic stem cell products, stem cell collection and storage know-how, and access to nanotechnology vital to cutting edge stem cell research
Now back to the company..product...........